Precision medicine is the tailoring of treatment plans to individual patients based on demographic, clinical, genetic, or other available data. This has the potential to greatly improve a patient’s clinical outcomes and their quality of life. Medical studies often involve time-to-event outcomes. One major challenge for analyzing time-to-event data is that some observations do not incur an event during their window of observation. Standard precision medicine methods cannot be used with right censored data without producing biased estimates. Thus, there is a need to develop precision medicine methods adapted to the censored data setting. In this manuscript we propose a number of extensions of precision medicine methods to right censored data....
Random forests have become one of the most popular machine learning tools in recent years. The main ...
This article presents a multiple imputation method for sensitivity analyses of time-to-event data wi...
The big data age has brought with it challenges and opportunities for biomedical decision making. Ne...
Precision medicine is formalized through the identification of individualized treatment rules (ITRs)...
Precision health has been an increasingly popular solution to improve health care quality and guide ...
In many medical studies, the outcome of interest may be the time from a starting point to a predefin...
Individualized treatment rules recommend treatments based on individual patient characteristics in o...
There has been increasing interest in discovering precision medicine in current drug development. On...
In precision medicine, predicting the risk of an event during a specific period may help, for exampl...
The rise of precision medicine has ushered in manifold opportunities and challenges, many of them li...
We presents a multiple imputation method for sensitivity analysis of continuous time-to-event data w...
Precision Medicine (PM) seeks to customize medical treatments for patients based on measurable and i...
The analysis of time-to-event data typically makes the censoring at random assumption, ie, that-cond...
In 2015 President Barack Obama announced the launch of the Precision Medicine Initiative, spurring a...
The primary analysis of time-to-event data typically makes the censoring at random assumption, that ...
Random forests have become one of the most popular machine learning tools in recent years. The main ...
This article presents a multiple imputation method for sensitivity analyses of time-to-event data wi...
The big data age has brought with it challenges and opportunities for biomedical decision making. Ne...
Precision medicine is formalized through the identification of individualized treatment rules (ITRs)...
Precision health has been an increasingly popular solution to improve health care quality and guide ...
In many medical studies, the outcome of interest may be the time from a starting point to a predefin...
Individualized treatment rules recommend treatments based on individual patient characteristics in o...
There has been increasing interest in discovering precision medicine in current drug development. On...
In precision medicine, predicting the risk of an event during a specific period may help, for exampl...
The rise of precision medicine has ushered in manifold opportunities and challenges, many of them li...
We presents a multiple imputation method for sensitivity analysis of continuous time-to-event data w...
Precision Medicine (PM) seeks to customize medical treatments for patients based on measurable and i...
The analysis of time-to-event data typically makes the censoring at random assumption, ie, that-cond...
In 2015 President Barack Obama announced the launch of the Precision Medicine Initiative, spurring a...
The primary analysis of time-to-event data typically makes the censoring at random assumption, that ...
Random forests have become one of the most popular machine learning tools in recent years. The main ...
This article presents a multiple imputation method for sensitivity analyses of time-to-event data wi...
The big data age has brought with it challenges and opportunities for biomedical decision making. Ne...